Research, editing : Gan Yung Chyan, KUCINTA SETIA
News on disease control
News (1) to (2) / Source : Rhoda Wilson, The Expose / https://expose-news.com/2022/10/12/get-vaccinated-for-others-was-always-a-lie/
News (1)
Pfizer admits to EU Parliament they NEVER tested whether Covid Vaccine prevented transmission or infection
After Pfizer’s CEO Albert Bourla declined to appear before the European Parliament to answer questions, Janine Small attended a parliamentary hearing on 10 October 2022 in his stead. Member of the European Parliament (“MEP”) Rob Roos from the Netherlands asked her a simple “yes” or “no” question: Was the Pfizer Covid vaccine tested for stopping transmission of the virus before it entered the market?
Janine Small answered, “No.”
This removed the entire legal basis for the Covid passport, MEP Rob Roos said. “This is scandalous. Millions of people worldwide felt forced to get vaccinated because of the myth that ‘you do it for others’.”
News (2)
"Get vaccinated for others" is a lie
“Get vaccinated for others” was always a lie, tweeted MEP Rob Roos on 11 October 2022.
This huge admission was made during the second debate of the European Parliament’s special committee on Covid-19 (“COVID”, covid) with representatives from pharmaceutical companies held on Monday, 10 October 2022. Representatives from five pharmaceutical companies attended:
- Janine Small, President of International Developed Markets, Pfizer
- Dr Franz-Werner Haas, Chief Executive Officer, CureVac
- Stanley Erck, Chief Executive Officer, Novavax
- Roger Connor, President Global Vaccines, Glaxo Smith Kline
- Carlos Montañés, Executive Vice-President, HIPRA
Readers can watch the full debate HERE.
The first debate was held on 5 September 2022 with representatives from Gilead Sciences, Sanofi, AstraZeneca and Moderna.
Further reading: MEP Grills AstraZeneca and Moderna About Vaccines and Vaccine Contracts During EU Covid Committee Meeting
Video
Press conference after Pfizer CEO Albert Bourla refused to answer in front of European Parliament
No comments:
Post a Comment